STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α. (Q38979390)

8 September 2017

STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α. (English)

1 reference

8 September 2017

1 reference

Chi Zhang

1

1 reference

8 September 2017

Xi Yang

2

1 reference

8 September 2017

Qu Zhang

3

1 reference

8 September 2017

Qing Guo

4

1 reference

8 September 2017

Jia He

5

1 reference

8 September 2017

Qin Qin

6

1 reference

8 September 2017

Hongcheng Zhu

7

1 reference

8 September 2017

Jia Liu

8

1 reference

8 September 2017

Liangliang Zhan

9

1 reference

8 September 2017

Jing Lu

10

1 reference

8 September 2017

Zheming Liu

11

1 reference

8 September 2017

Liping Xu

12

1 reference

8 September 2017

Jianxin Ma

13

1 reference

8 September 2017

Shengbin Dai

14

1 reference

8 September 2017

Hongyan Cheng

15

1 reference

8 September 2017

Xinchen Sun

16

1 reference

8 September 2017

1 July 2014

1 reference

8 September 2017

1 reference

8 September 2017

35

1 reference

8 September 2017

10

1 reference

8 September 2017

9793-9799

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2207-3

8 September 2017

0 references

cites work

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

HIF-1 and tumour radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Cancer prevention by targeting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Hypoxia-induced snail expression through transcriptional regulation by HIF-1α in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2207-3

JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma

21 January 2018

1 reference

12 December 2020

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

1 reference

12 December 2020

STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.

1 reference

12 December 2020

Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin

1 reference

12 December 2020

10.1007/S13277-014-2207-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference